Evaluating relugolix for the treatment of prostate cancer in real-world settings of care: the OPTYX study protocol. - Spratt DE; Dorff T; McKay RR; Lowentritt BH; Fallick M; Gatoulis SC; Flanders SC; Ross AE (Future oncology (London, England), 2024)